{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:23:24Z","timestamp":1793237004537,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005485","name":"American College of Cardiology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jacc.2021.01.011","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:26:12Z","timestamp":1615249572000},"page":"1357-1367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["A Test in Context: Interpretation of High-Sensitivity Cardiac Troponin Assays in Different Clinical Settings"],"prefix":"10.1016","volume":"77","author":[{"given":"Inbar","family":"Raber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cian P.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2021.01.011_bib1","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1373\/clinchem.2016.255109","article-title":"Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care","volume":"63","author":"Apple","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2021.01.011_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa624","article-title":"2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","author":"Collet","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2021.01.011_bib4","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jacc.2018.12.046","article-title":"Recommendations for institutions transitioning to high-sensitivity troponin testing: JACC Scientific Expert Panel","volume":"73","author":"Januzzi","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2018.09.082","article-title":"Cardiac troponin elevation in patients without a specific diagnosis","volume":"73","author":"Eggers","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib6","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/0002-9149(91)90466-X","article-title":"Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction","volume":"67","author":"Katus","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/jamacardio.2016.0765","article-title":"Six-year change in high-sensitivity cardiac troponin t and risk of subsequent coronary heart disease, heart failure, and death","volume":"1","author":"McEvoy","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib8","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1001\/jama.2010.1768","article-title":"Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population","volume":"304","author":"de Lemos","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.01.011_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jacc.2018.10.065","article-title":"Single-molecule hsTnI and short-term risk in stable patients with chest pain","volume":"73","author":"Januzzi","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib10","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/CIRCULATIONAHA.117.032003","article-title":"Combining high-sensitivity cardiac troponin I and cardiac troponin T in the early diagnosis of acute myocardial infarction","volume":"138","author":"Linden","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/heartjnl-2015-308917","article-title":"Direct comparison of clinical decision limits for cardiac troponin T and I","volume":"102","author":"Kimenai","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2021.01.011_bib12","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1161\/CIRCULATIONAHA.118.038772","article-title":"High-sensitivity troponin I and incident coronary events, stroke, heart failure hospitalization, and mortality in the ARIC study","volume":"139","author":"Jia","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib13","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1373\/clinchem.2018.292086","article-title":"Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort","volume":"64","author":"Welsh","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2021.01.011_bib14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.clinbiochem.2015.04.013","article-title":"Cardiac troponin I levels in an elderly population from the community\u2014the implications of sex","volume":"48","author":"Eggers","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jacc.2021.01.011_bib15","article-title":"Highly sensitive cardiac troponins: the evidence behind sex specific cutoffs","volume":"9","author":"Bhatia","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.01.011_bib16","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacc.2013.12.032","article-title":"Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay","volume":"63","author":"Gore","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib17","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1373\/clinchem.2012.196634","article-title":"Factors influencing the 99th percentile of cardiac troponin I evaluated in community-dwelling individuals at 70 and 75 years of age","volume":"59","author":"Eggers","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2021.01.011_bib18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/CIRCULATIONAHA.114.014364","article-title":"High-sensitivity cardiac troponin T and risk of hypertension","volume":"132","author":"McEvoy","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib19","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1373\/clinchem.2012.185322","article-title":"Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome","volume":"58","author":"deFilippi","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2021.01.011_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2377-14-96","article-title":"Determinants of high sensitivity cardiac troponin T elevation in acute ischemic stroke","volume":"14","author":"Faiz","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jacc.2021.01.011_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00134-010-2051-x","article-title":"Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome","volume":"37","author":"R\u00f8sj\u00f8","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jacc.2021.01.011_bib22","article-title":"Myocardial injury in severe COVID-19 compared to non-COVID acute respiratory distress syndrome","author":"Metkus","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib23","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jacc.2020.06.068","article-title":"Cardiac troponin for assessment of myocardial injury in COVID-19","volume":"76","author":"Sandoval","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib25","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/heartjnl-2020-317007","article-title":"Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis","volume":"106","author":"Wei","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2021.01.011_bib26","first-page":"461","article-title":"Cardiac troponin and the true false positive","volume":"2","author":"Januzzi","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Case Rep"},{"key":"10.1016\/j.jacc.2021.01.011_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1373\/clinchem.2016.264523","article-title":"Rapid rule-out of acute myocardial injury using a single high-sensitivity cardiac troponin I measurement","volume":"63","author":"Sandoval","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2021.01.011_bib28","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1056\/NEJMoa1803377","article-title":"Application of high-sensitivity troponin in suspected myocardial infarction","volume":"380","author":"Neumann","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.01.011_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jacc.2019.05.058","article-title":"Myocardial infarction risk stratification with a single measurement of high-sensitivity troponin I","volume":"74","author":"Sandoval","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib30","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.119.042891","article-title":"A\u00a0randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT)","volume":"140","author":"Chew","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib31","first-page":"39","article-title":"RAPID-CPU: a prospective study on implementation of the ESC 0\/1-hour algorithm and safety of discharge after rule-out of myocardial infarction","volume":"9","author":"Stoyanov","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jacc.2021.01.011_bib32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jacc.2019.05.046","article-title":"Outcome of applying the ESC 0\/1-hour algorithm in patients with suspected myocardial infarction","volume":"74","author":"Twerenbold","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib33","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jamacardio.2019.2724","article-title":"Myocardial injury in the era of high-sensitivity cardiac troponin assays: a practical approach for clinicians","volume":"4","author":"McCarthy","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib34","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/CIRCULATIONAHA.105.609974","article-title":"Prevalence and determinants of troponin t elevation in the general population","volume":"113","author":"Wallace","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib35","first-page":"355","article-title":"Association of high-sensitivity troponin with cardiac CT angiography evidence of myocardial and coronary disease in a primary prevention cohort of men: results from MACS","volume":"4","author":"Rahman","year":"2019","journal-title":"J\u00a0Appl Lab Med"},{"key":"10.1016\/j.jacc.2021.01.011_bib36","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1001\/jama.2010.1708","article-title":"Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults","volume":"304","author":"deFilippi","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.01.011_bib37","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/CIRCULATIONAHA.110.005264","article-title":"Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study","volume":"123","author":"Saunders","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib38","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1161\/CIRCULATIONAHA.118.038529","article-title":"Cardiac troponin T and Troponin I in the general population","volume":"139","author":"Welsh","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib39","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/eurheartj\/ehw172","article-title":"Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium","volume":"37","author":"Blankenberg","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2021.01.011_bib40","first-page":"401","article-title":"High-sensitivity cardiac troponin i levels and prediction of heart failure: results from the BiomarCaRE Consortium","volume":"8","author":"Yan","year":"2020","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2021.01.011_bib41","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/CIRCULATIONAHA.119.043628","article-title":"Racial differences in malignant left ventricular hypertrophy and incidence of heart failure: a multicohort study","volume":"141","author":"Lewis","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jamacardio.2018.4300","article-title":"Association of cardiac injury and malignant left ventricular hypertrophy with risk of heart failure in African Americans: The Jackson Heart Study","volume":"4","author":"Pandey","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib43","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1161\/CIRCULATIONAHA.119.043337","article-title":"Incorporation of biomarkers into risk assessment for allocation of antihypertensive medication according to the 2017 ACC\/AHA High Blood Pressure Guideline: a pooled cohort analysis","volume":"140","author":"Pandey","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2337\/dc16-1541","article-title":"High-sensitivity cardiac troponin T (hs-cTnT) as a predictor of incident diabetes in the Atherosclerosis Risk in Communities Study","volume":"40","author":"Whelton","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2021.01.011_bib45","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.jacc.2016.10.020","article-title":"High-sensitivity cardiac troponin, statin therapy, and risk of coronary heart disease","volume":"68","author":"Ford","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jacc.2020.05.057","article-title":"Atherosclerotic cardiovascular disease risk stratification based on measurements of troponin and coronary artery calcium","volume":"76","author":"Sandoval","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib47","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jcmg.2018.01.021","article-title":"High-sensitivity troponin I and coronary computed tomography in symptomatic outpatients with suspected coronary artery disease. insights from the PROMISE Trial","volume":"12","author":"Januzzi","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2021.01.011_bib48","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa0805299","article-title":"A\u00a0sensitive cardiac troponin T assay in stable coronary artery disease","volume":"361","author":"Omland","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.01.011_bib49","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1373\/clinchem.2011.164574","article-title":"High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population","volume":"57","author":"Kavsak","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2021.01.011_bib50","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1373\/clinchem.2012.183319","article-title":"Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up","volume":"58","author":"Koenig","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2021.01.011_bib51","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/jamainternmed.2013.116","article-title":"High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study","volume":"173","author":"Beatty","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2021.01.011_bib52","article-title":"High-sensitivity troponin I levels and coronary artery disease severity, progression, and long-term outcomes","volume":"7","author":"Samman Tahhan","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.01.011_bib53","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jacc.2018.06.055","article-title":"Type 2 myocardial infarction and the hospital readmission reduction program","volume":"72","author":"McCarthy","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib54","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1161\/CIRCULATIONAHA.116.024632","article-title":"Serial measurement of high-sensitivity troponin I and cardiovascular outcomes in patients with type 2 diabetes mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care)","volume":"135","author":"Cavender","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib55","article-title":"Clinical and biomarker predictors of expanded heart failure outcomes in patients with type 2 diabetes mellitus after a recent acute coronary syndrome: insights from the EXAMINE Trial","volume":"9","author":"Sharma","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.01.011_bib56","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jamacardio.2020.2981","article-title":"Clinical application of high-sensitivity troponin testing in the atherosclerotic cardiovascular disease framework of the current cholesterol guidelines","volume":"5","author":"Marston","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib57","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jacc.2003.06.001","article-title":"Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality","volume":"42","author":"Gibson","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jama.290.3.353","article-title":"Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis","volume":"290","author":"deFilippi","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.01.011_bib59","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/j.ajkd.2012.11.034","article-title":"Association of cardiac troponin T with left ventricular structure and function in CKD","volume":"61","author":"Mishra","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2021.01.011_bib60","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCULATIONAHA.117.031560","article-title":"Prognostic value of high-sensitivity troponin T in chronic heart failure: an individual patient data meta-analysis","volume":"137","author":"Aimo","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib61","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1373\/clinchem.2016.261644","article-title":"Cardiac troponin T: smaller molecules in patients with end-stage renal disease than after onset of acute myocardial infarction","volume":"63","author":"Mingels","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2021.01.011_bib62","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.amjcard.2013.10.003","article-title":"High-sensitivity troponin T is more susceptible than high-sensitivity troponin I to impaired renal function","volume":"112","author":"Lippi","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib63","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1161\/01.CIR.0000041254.30637.34","article-title":"Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease","volume":"106","author":"Apple","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib64","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/CIRCULATIONAHA.117.028901","article-title":"0\/1-hour triage algorithm for myocardial infarction in patients with renal dysfunction","volume":"137","author":"Twerenbold","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib65","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.117.030320","article-title":"High-sensitivity cardiac troponin and the risk stratification of patients with renal impairment presenting with suspected acute coronary syndrome","volume":"137","author":"Miller-Hodges","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib66","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1161\/CIRCULATIONAHA.114.014245","article-title":"Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction","volume":"131","author":"Twerenbold","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib67","article-title":"Cardiac troponins for the diagnosis of acute myocardial infarction in chronic kidney disease","volume":"7","author":"Kraus","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.01.011_bib68","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1253\/circj.CJ-13-1372","article-title":"High-sensitivity cardiac troponin T predicts non-cardiac mortality in heart failure","volume":"78","author":"Nakamura","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2021.01.011_bib69","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/ejhf.341","article-title":"Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study","volume":"17","author":"Felker","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2021.01.011_bib70","article-title":"High-sensitivity troponin I in hospitalized and ambulatory patients with heart failure with preserved ejection fraction: insights from the Heart\u00a0Failure Clinical Research Network","volume":"7","author":"Fudim","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.01.011_bib71","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/CIRCULATIONAHA.106.655076","article-title":"Prognostic value of very low plasma concentrations of troponin t in patients with stable chronic heart failure","volume":"116","author":"Latini","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib72","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1373\/clinchem.2009.141341","article-title":"Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro\u2013B-type natriuretic peptide measurements","volume":"56","author":"Alehagen","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2021.01.011_bib73","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/eurjhf\/hfr049","article-title":"Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure","volume":"13","author":"Tentzeris","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2021.01.011_bib74","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.cca.2011.05.007","article-title":"High-sensitive troponin T and I are related to invasive hemodynamic data and mortality in patients with left-ventricular dysfunction and precapillary pulmonary hypertension","volume":"412","author":"Eggers","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacc.2021.01.011_bib75","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjcard.2012.04.033","article-title":"Prediction of outcome by highly sensitive troponin t in outpatients with chronic systolic left ventricular heart failure","volume":"110","author":"Egstrup","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib76","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5603\/CJ.a2015.0058","article-title":"High-sensitivity troponin is associated with high risk clinical profile and outcome in acute heart failure","volume":"23","author":"Diez","year":"2016","journal-title":"Cardiol J"},{"key":"10.1016\/j.jacc.2021.01.011_bib77","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ejhf.988","article-title":"Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study","volume":"20","author":"Welsh","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2021.01.011_bib78","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/CIRCULATIONAHA.111.044149","article-title":"Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials","volume":"125","author":"Masson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib79","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1161\/01.CIR.103.16.2035","article-title":"Preload induces troponin I degradation independently of myocardial ischemia","volume":"103","author":"Feng","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.011_bib80","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2019.06.005","article-title":"Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure","volume":"293","author":"Aimo","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2021.01.011_bib81","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12265-015-9618-4","article-title":"Concentrations of highly sensitive cardiac troponin-I predict poor cardiovascular outcomes and adverse remodeling in chronic heart failure","volume":"8","author":"Motiwala","year":"2015","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.jacc.2021.01.011_bib82","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/ejhf.911","article-title":"The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction","volume":"19","author":"Gohar","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2021.01.011_bib83","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/ejhf.414","article-title":"Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction","volume":"17","author":"Sanders-van Wijk","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2021.01.011_bib84","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1093\/eurheartj\/ehu189","article-title":"High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis","volume":"35","author":"Chin","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2021.01.011_bib85","article-title":"Derivation and external validation of a high-sensitivity cardiac troponin-based proteomic model to predict the presence of obstructive coronary artery disease","volume":"9","author":"McCarthy","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.01.011_bib86","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007975","article-title":"Single-molecule counting of high-sensitivity troponin I in patients referred for diagnostic angiography: results from the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) study.","volume":"7","author":"McCarthy","year":"2018","journal-title":"J Am Heart Assoc"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721000759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721000759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:38:56Z","timestamp":1760017136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109721000759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":86,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0735109721000759"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2021.01.011","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Test in Context: Interpretation of High-Sensitivity Cardiac Troponin Assays in Different Clinical Settings","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2021.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}